Acquired von Willebrand disease: Potential contribution of the VWF:CB to the identification of functionally inhibiting auto-antibodies to von Willebrand factor [7]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 9, 2006, Pages 2085-2088

  Coleman, R ^a   Favaloro, Emmanuel J ^b   Soltani, S ^b   Keng, T B ^a  

^a SULLIVAN NICOLAIDES PATHOLOGY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; BLOOD DERIVATIVE; COLLAGEN; PROTEIN INHIBITOR; RISTOCETIN; VON WILLEBRAND FACTOR;

ADULT; ANTIGEN DETECTION; BINDING ASSAY; BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BONE ATROPHY; CASE REPORT; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL LABORATORY; DIAGNOSTIC ERROR; FEMALE; HEMATOLOGICAL PROCEDURES; HUMAN; HYPOTHYROIDISM; LETTER; PRIORITY JOURNAL; PROTEIN FUNCTION; TREATMENT WITHDRAWAL; VON WILLEBRAND DISEASE;

AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; VON WILLEBRAND DISEASE; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 33747163264     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02072.x     Document Type: Letter

References (12)

1. Federici AB. Willebrand syndrome: An underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Semin Hematol 2006; 43: S48-58.
2. Kumar S, Pruthi RK, Nichols WL. Estimation of prevalence and natural history of acquired von Willebrand disease. Haemophilia 2000; 6: 212-21.
3. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE, Subcommittee on von Willebrand Factor. Acquired von Willebrand syndrome: Data from an international registry. Thromb Haemost 2000; 84: 345-9 Erratum in: Thromb Haemost 2000; 84: 739.
4. Siaka C, Rugeri L, Caron C, Goudemand J. A new ELISA assay for diagnosis of acquired von Willebrand Syndrome. Haemophilia 2003; 9: 303-8.
5. Laffan M, Brown SA, Collins PW, Cumming AM, Hill FG, Keeling D, Peake IR, Pasi KJ. The diagnosis of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 2004; 10: 199-217.
6. van Genderen PJJ, Vink T, Michelo JJ, van't Veer MB, Sixma JJ, van Vliet HDM. Willebrand disease caused by an antibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood 1994; 84: 3780-4.
7. Mohri H, Hisanaga S, Mishima A, Fujimoto S, Uezono S, Okudo T. Auto-antibody inhibits binding of von Willebrand factor to glycoprotein Ib and collagen in multiple myeloma: Recognition sites present on the A1 loop and A3 domains of von Willebrand factor. Blood Coag Fibrin 1998; 9: 91-7.
8. Favaloro EJ, Mehrabani PA, Koutts J. Laboratory assessment of von Willebrand factor: Altered interpretation of laboratory data, and altered diagnosis of von Willebrand's disease, as influenced by the use of different vWF assays and assay conditions. Clin Appl Thromb/Hemost 1997; 3: 110-8.
9. Favaloro EJ, Bonar R, Sioufi J, Hertzberg M, Street A, Lloyd J, Marsden K (on behalf of the RCPA QAP in Haematology Haemostasis Committee). Laboratory diagnosis of von Willebrand Disorder: Current practice in the southern hemisphere. Am J Clin Pathol 2003; 119: 882-93.
10. Favaloro EJ. Willebrand factor (VWF) collagen binding (activity) assay (VWF:CBA) in the diagnosis of von Willebrand's disoAder (VWD): a 15-year journey. Semin Thromb Hemost 2002; 28: 191-202.
11. Wu D, Vanhoorelbeke K, Cauwenberghs N, Meiring M, Depraetere H, Kotze HF, Deckmyn H. Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. Blood 2002; 99: 3623-8.
12. Sadler JE. Does VWF bind collagen after all? Blood 2002; 99: 3491.